European Landscape Assessment
HTA Decision Analysis
Payer research and advisory boards
Joint/Parallel Scientific Advice
Key Country Market Insights
Market Access & Value Strategy
Value Story & Message Development
Evidence Gap Analysis
Evidence Generation Planning
Value-based Price Potential
Multi-national HTA strategy
Country HTA Submissions
European Launch Management
is the Managing Director of Europe for AESARA. Gavin delivers measurable business improvement for global life sciences clients through advising executives on value & access strategy, communications and organizational design.
With over 21 years of leadership experience, including 17 in life sciences, Gavin believes the life sciences sector is a social good and that a regulated market is the best way of delivering innovation and value. Consequently, he works with clients in Development and Commercialization functions to optimize how they demonstrate scientifically-sound cost-risk-benefit and, by doing so, deliver value to patients, to payers and to investors.
Prior to AESARA, Gavin was on the Executive Committee of life sciences services company Kinapse; held a change management role in Pfizer R&D; and began his working life as an officer in the Royal Air Force.
has international experience acquired over thirty+ years in the pharma industry in medium-sized and large companies. She holds a PhD in Pharmacy and a Masters of Public Health from Sciences Po, Paris. She is an expert in Market Access for innovative drugs.
As a member of the leadership team of the French affiliate of a leading US biotech for 15 years, she helped establish & develop the company locally, directly negotiated product prices & access conditions, developed relationships with regulators, payors and KOLs. She also actively participated in the evidence generation and early access program strategies for our innovative therapies, including orphan drug products, highlighting the unmet needs and the products’ unique attributes.
She also has strong pan-European experience in Market Access, having most recently led the Market Access Excellence function for Europe, creating common understanding, tools, measures and co-operation between countries.
Having both the big picture perspective and the methodological know-how, our strategic consultants come from industry and have molecule-to-launch experience in a complex and changing global healthcare landscape.
